Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Cash & Current Investments (2022 - 2025)

CervoMed (CRVO) has disclosed Cash & Current Investments for 9 consecutive years, with $20.9 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments fell 46.39% to $20.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.9 million through Dec 2025, down 46.39% year-over-year, with the annual reading at $20.9 million for FY2025, 46.39% down from the prior year.
  • Cash & Current Investments hit $20.9 million in Q4 2025 for CervoMed, down from $27.3 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $46.5 million in Q3 2024 to a low of $6.4 million in Q1 2024.
  • Historically, Cash & Current Investments has averaged $25.5 million across 4 years, with a median of $26.6 million in 2022.
  • Biggest five-year swings in Cash & Current Investments: plummeted 63.89% in 2024 and later surged 453.36% in 2025.
  • Year by year, Cash & Current Investments stood at $16.5 million in 2022, then plummeted by 52.78% to $7.8 million in 2023, then surged by 399.46% to $38.9 million in 2024, then crashed by 46.39% to $20.9 million in 2025.
  • Business Quant data shows Cash & Current Investments for CRVO at $20.9 million in Q4 2025, $27.3 million in Q3 2025, and $33.5 million in Q2 2025.